Related Experiment Video
Updated: Jun 3, 2026

Isolation of Rat Portal Fibroblasts by In situ Liver Perfusion
Published on: June 29, 2012
[The role of iron and hepcidin in hepatic fibrosis]
Jin-Ying Zhao1, Yan-Wei Li, Lin Li
1Department of anatomy, Shaoyang Medical College, Shaoyang 422001, China.
Abstract:
Liver iron overload can be found in a number of different chronic liver diseases. Iron is proposed to play a role in promoting hepatic fibrosis by various mechanisms, including iron-catalyzed production of free radical and lipid peroxidation, alteration of essential biomolecules, triggering cell apoptosis and necrosis, and activation and transformation of the hepatic stellate cell into a myofibroblastic cell. Recent evidences demonstrate that the decrease of hepcidin, a 25-amino acid peptide produced by the hepatocytes, may play a significant role in promoting hepatic iron overload in various chronic liver diseases. Therefore, the supplemental hepcidin therapy may reduce liver iron concentration. Hepcidin or hepcidin-related therapeutics could find a place in the treatment of various iron overload diseases and hepatic fibrosis.
Related Concept Videos
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cirrhosis I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Portal Hypertension
